These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2908137

  • 1. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M, Danek L, Smiałowski A.
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [Abstract] [Full Text] [Related]

  • 2. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH, Bergstrom DA, Weick BG, Walters JR.
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 4. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988 Mar; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
    Freeman AS, Kelland MD, Rouillard C, Chiodo LA.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):790-7. PubMed ID: 2567352
    [Abstract] [Full Text] [Related]

  • 6. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Synapse; 1990 Jun; 5(2):83-93. PubMed ID: 2309160
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 8. Prolonged treatment with antidepressant drugs increases the excitatory effect of quinpirole in hippocampal slices.
    Bijak M.
    Pol J Pharmacol; 1993 Apr; 45(4):381-90. PubMed ID: 7906990
    [Abstract] [Full Text] [Related]

  • 9. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 10. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A, Kulkarni SK, Nayar U.
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [Abstract] [Full Text] [Related]

  • 11. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 12. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 14. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY, Asdourian D, Chiodo LA.
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [Abstract] [Full Text] [Related]

  • 16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 17. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
    Yoshikawa T, Fukamauchi F, Shibuya H, Takahashi R.
    Neuropeptides; 1989 May; 13(2):103-5. PubMed ID: 2567971
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 19. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 20. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Eur J Pharmacol; 1988 Aug 02; 152(3):289-300. PubMed ID: 2906003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.